{"nct_id":"NCT02574455","title":"Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)","status":"COMPLETED","status_verified_date":"2022-05","start_date":"2017-11-07","start_date_type":"ACTUAL","primary_completion_date":"2020-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}